Issue #7: The GLP-1 Gold Rush Every issue of The American Healthcare Conundrum identifies one fixable, quantifiable problem in the US healthcare system, builds the data case, and recommends a specific policy fix
The Contenders: Sun Pharma: Planning a Day 1 launch with brands Noveltreat and Sematrinity
At this point, the 10mg vial barely covers one dose
For context on expected results, the retatrutide results timeline covers what to expect at each stage
Miguens-Gomez 2021): A fast, neural-based release within 10-15 minutes of eating A slower, nutrient-based release ~60 minutes after eating, especially when nutrients reach the lower GI tract, Eating too quickly may short-circuit the gut-brain connection
All eight reported studies have demonstrated the noninferiority of GLP-1RAs compared to placebo regarding MACE